Skip to main content

stock

CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

What CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live CRL price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on CRL.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
47,738,872 as of 2026-07-25 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
2.3%
Net
-6.0%

Returns

ROE
-8.4%
ROA
-3.2%

Health

Current ratio
1.3x
Debt/equity
—

Deep value

NCAV
-$3.11B
NCAV per share
-$65.24
Price/NCAV
Locked
NNWC
-$3.74B
NNWC per share
-$78.44
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-27; balance sheet at 2026-06-27.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-27$1.00B—$119.89M-$1.48M
10-Q filed 2026-08-05
2026-03-28$995.83M—$119.90M-$14.84M
10-Q filed 2026-05-07
2025-12-27$994.23M—-$283.44M-$276.56M
10-K filed 2026-02-18
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-27$1.00B—$133.80M$54.42M
10-Q filed 2025-11-05
2025-06-28$1.03B—$100.13M$52.33M
10-Q filed 2026-08-05
2025-03-29$984.17M—$74.67M$25.47M
10-Q filed 2026-05-07
2024-12-28$1.00B—-$167.69M-$214.50M
10-K filed 2026-02-18
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-28$1.01B—$117.41M$69.66M
10-Q filed 2025-11-05
Assets
$7.53B
Equity
$2.84B

Balance as of 2026-06-27.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-27$4.02B$25.16M-$144.34M—
2024-12-28$4.05B$227.35M$22.20M—
2023-12-30$4.13B$617.26M$474.62M—
2022-12-31$3.98B$650.98M$486.23M—
2021-12-25$3.54B$589.86M$390.98M—
2020-12-26$2.92B$432.73M$364.30M—
2019-12-28$2.62B$351.15M$252.02M—
2018-12-29$2.27B$331.38M$226.37M—
2017-12-30$1.86B$288.28M$123.36M—
2016-12-31$1.68B$237.55M$154.76M—

Company filings

events

  • Regulation FD disclosure

    Regulation FD disclosure
    Sep 248-K
  • Results

    Results
    Aug 58-K
  • Executive or director change, Shareholder vote results

    Executive or director changeShareholder vote results
    May 118-K
  • Results

    Results
    May 78-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Feb 258-K
  • Executive or director change

    Executive or director change
    Feb 188-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Coleman Glenn

    EVP & Chief Financial Officer

    Buy$2,974

    Oct 2, 4:27 PM ET

  • FOSTER JAMES C

    Director

    Sale$10,068,300

    Aug 27, 4:21 PM ET

  • Parisotto Shannon M

    CEVP, Disc & Safety Assessment

    Sale$599,711

    Aug 20, 4:33 PM ET

  • Andrews Nancy C

    Director

    Sale$163,443

    Aug 20, 4:31 PM ET

  • Girshick Birgit

    Chief Executive Officer, Director

    Sale$1,819,350

    Aug 13, 4:37 PM ET

All insider trades for CRL

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named CRL, and the market events around them.

Sign in to see this

Board

The CRL board could not be loaded.

Retry the CRL board

nakagai

Signals on CRL come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the CRL board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): SEC filings, financials and insider trades · Nakagai